Comparative Analysis of Actual Cost and Indonesian Case-Based Groups Rate in Inpatient Suspect of Acute Hepatitis of Unknown Aetiology

Main Article Content

Siti Maemun
Aninda Dinar Widiantari
Nur Aliza
Vivi Setiawaty
Lhuri Dwianti Rahmartani

Abstract

Background: Hospitals are crucial in implementing the referral and National Health Insurance (NHI) systems. The reimbursement structure by the Social Security Administrator for Health (SSAH) relies on the Indonesian Case-Based Groups (INA-CBG) method. This study aims to discern the variance between hospital inpatient costs and the corresponding inpatient INA-CBG rates, specifically for patients with suspected acute hepatitis of unknown aetiology (AHUA).


Methods: This research used a descriptive cross-sectional method. We compared the actual hospitalisation cost and INA-CBG’s tariff in an Indonesian tertiary hospital from July to December 2022. The study encompasses patients with AHUA and uses a saturation sampling method.


Results: Of the 17 patients suspected of AHUA, 16 made payments through NHI. A comprehensive analysis reveals that the total hospital costs based on INA-CBG rates show a deficit of IDR 21,604,464, reflecting a difference of 13.96%. The primary diagnoses among patients vary, with presentations of a combination of viral, bacterial, and parasitic infections alongside bile or liver disorders. The hospital incurred losses from services rendered to 10 patients. Notably, the significant allocations of hospital costs include laboratory (46.84%), pharmacy (19.01%), and accommodation (17.28%).


Conclusion: To maintain effective cost control in inpatient services, the focus should prioritise medical appropriateness, explicitly referencing Clinical Practice Guidelines (CPG) and Clinical Pathways.

Article Details

How to Cite
1.
Maemun S, Widiantari AD, Aliza N, Setiawaty V, Rahmartani LD. Comparative Analysis of Actual Cost and Indonesian Case-Based Groups Rate in Inpatient Suspect of Acute Hepatitis of Unknown Aetiology. Malays J Med Sci [Internet]. 2026 Feb. 28 [cited 2026 Mar. 7];33(1):145–154. Available from: https://ejournal.usm.my/mjms/article/view/mjms_vol33-no1-2026_12
Section
Original Articles

References

Gani A, Budiharsana MP. The consolidated report on Indonesia health sector review 2018. Jakarta: Ministry of National Development Planning of the Republic of Indonesia; 2019. p. 56.

World Health Organization. Severe acute hepatitis of unknown aetiology in children – multi-country. [Internet]. Geneva: WHO; 2022 [Retrieved 2023 Jan 11]. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON400

Kementerian Kesehatan Republik Indonesia. Kasus hepatitis akut yang belum diketahui penyebabnya. Jakarta: Kemenkes; 2023.

Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/1491/2023 tentang rumah sakit jejaring pengampuan pelayanan penyakit infeksi emerging. Indonesia: Kemenkes RI; 2023.

Kementerian Kesehatan Republik Indonesia. KMK RI Nomor HK.01.07/Menkes/104/2020 tentang penetapan infeksi novel coronavirus (infeksi 2019 n-CoV) sebagai penyakit yang dapat menimbulkan wabah dan penanggulangannya. Indonesia: Kemenkes RI; 2020. p. 7–10.

Ministry of Health of the Republic of Indonesia. Strategic planning Ministry of Health 2015–2019: decree of the Minister of Health of the Republic of Indonesia Number HK.02.02/Menkes/52/2015. Indonesia: Ministry of Health; 2015.

Badan Penyelenggara Jaminan Sosial Kesehatan. Ringkasan eksekutif laporan pengelolaan program dan laporan keuangan BPJS Kesehatan tahun 2019 (auditan) [Executive Summary of Program Management Reports and BPJS Health Financial Reports 2019 (Audited)]. Jakarta: BPJS Kesehatan; 2020.

Kementerian Keuangan Republik Indonesia. Buku II nota keuangan beserta anggaran pendapatan dan belanja negara tahun anggaran 2020. Jakarta: Kementerian Keuangan; 2020.

Kementerian Keuangan Republik Indonesia. Buku II nota keuangan beserta anggaran pendapatan dan belanja negara tahun anggaran 2021. Jakarta: Kementerian Keuangan; 2021.

Mathur MR, Williams DM, Reddy KS, Watt RG. Universal health coverage: a unique policy opportunity for oral health. J Dent Res. 2015;94(3 Suppl):3S–5S. https://doi.org/10.1177/0022034514565648

World Health Assembly. Fifty-eighth World Health Assembly. WHA58/2005/REC/1. Geneva: WHO; 2005. p. 1–159.

Puspandari DA, Mukti AG, Kusnanto H, Kebijakan P, Asuransi M. Faktor-faktor yang mempengaruhi biaya obat pasien kanker payudara di rumah sakit di Indonesia (Determinant factors of drug cost for breast cancer patient in Indonesia). J Kebijakan Kesehatan Indonesia. 2015;4(3):104–108.

Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2019;68(11):1791–1797. https://doi.org/10.1093/cid/ciy776

Rashidi B, Kobewka DM, Campbell DJT, Forster AJ, Ronksley PE. Clinical factors contributing to high-cost hospitalizations in a Canadian tertiary care centre. BMC Health Serv Res. 2017;17(1):777. https://doi.org/10.1186/s12913-017-2746-6

Chaikledkaew U, Pongchareonsuk P, Chaiyakunapruk N, Ongphiphadhanakul B. Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals. Value Health. 2008;11(Suppl 1):S69–S74. https://doi.org/10.1111/j.1524-4733.2008.00369.x

Ambarriani AS. Hospital financial performance in the Indonesian National Health Insurance era. Rev Integr Bus Econ Res. 2014;4(1):367–379.

Fung MK. An interdisciplinary journal on applied business and economics research. Rev Integr Bus Econ Res;2(2);2013.

Rahayuningrum IO, Tamtomo DG, Suryono A. Analisis tarif rumah sakit dibandingkan dengan tarif Indonesian Case Based Groups pada pasien rawat inap peserta Jaminan Kesehatan Nasional di rumah sakit. Prosiding Implementasi Penelitian Pada Pengabdian Menuju Masyarakat Mandiri Berkemajuan; 2017 Feb 25; Semarang, Indonesia. Universitas Muhammadiyah Semarang; 2017. p. 214–223. https://jurnal.unimus.ac.id/index.php/psn12012010/article/view/2300

Centers for Disease Control and Prevention. Persons under investigation: children with acute hepatitis of unknown etiology. [Internet]. 2022 [Retrieved 2023 Jan 11]. Available at: https://www.cdc.gov/ncird/investigation/hepatitis-unknown-cause/updates.html

World Health Organization. Severe acute hepatitis of unknown aetiology in children – multi-country, 12 July 2022. [Internet]. 2022 [Retrieved 2023 Jan 11]. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON400

Patel N, Sethi Y, Kaka N, Kaiwan O, Gupta I, Shaheen RS, et al. Acute hepatitis of unknown origin in paediatric age group: recent outbreaks and approach to management. J Clin Med. 2022;12(1):9. https://doi.org/10.3390/jcm12010009

Kementerian Kesehatan Republik Indonesia. Keputusan Direktur Jenderal Pelayanan Kesehatan Nomor HK.02.02/I/1684/2022 tentang tata laksana hepatitis akut pada anak yang belum diketahui penyebabnya di fasilitas pelayanan kesehatan. Indonesia; 2022. p. 7.

Angelika SM, Bakhtiar HS. Health financing planning in hospital. J Madika Hutama. 2022;3(2):1903–1912.

Wilder-Smith A, Osman S. Public health emergencies of international concern: a historic overview. J Travel Med. 2020;27(8):taaa227. https://doi.org/10.1093/jtm/taaa227

McCoy D, Roberts S, Daoudi S, Kennedy J. Global health security and the health-security nexus: principles, politics and praxis. BMJ Glob Health. 2023;8(9):e013067. https://doi.org/10.1136/bmjgh-2023-013067

de Araújo GR, de Castro PASV, Ávila IR, Bezerra JMT, Barbosa DS. Effects of public health emergencies of international concern on disease control: a systematic review. Rev Panam Salud Publica. 2023;47:1–9. https://doi.org/10.26633/RPSP.2023.74

Schell D, Wang M, Huynh TLD. This time is indeed different: a study on global market reactions to public health crisis. J Behav Exp Finance. 2020;27:100349. https://doi.org/10.1016/j.jbef.2020.100349

Marsh. Empat (4) indikator utama dan cara tolok ukur efektif biaya rumah sakit di Indonesia. [Internet]. 2022 [Retrieved 2024 Jan 2]. Available at: https://www.marsh.com/id/en/services/employee-health-benefits/insights/cost-of-care.html

Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor 1138/Menkes/SK/XI/2009 tentang penetapan Rumah Sakit Penyakit Infeksi Prof. Dr. Sulianti Saroso sebagai pusat kajian dan rujukan nasional penyakit infeksi. Indonesia; 2009.

Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/413/2020 tentang Pedoman Pencegahan dan Pengendalian Coronavirus Disease 2019 (COVID-19). Indonesia; 2020.

Murrin S. Hospitals reported improved preparedness for emerging infectious diseases after the Ebola outbreak. Report No. OEI-06-15-00230. Washington (DC): U.S. Department of Health and Human Services, Office of Inspector General; 2018.

Anesi GL, Lynch Y, Evans L. A conceptual and adaptable approach to hospital preparedness for acute surge events due to emerging infectious diseases. Crit Care Explor. 2020;2(4):e0110. https://doi.org/10.1097/CCE.0000000000000110

World Health Organization; Ministry of Public Health Thailand. Joint intra-action review of the public health response to COVID-19 in Thailand, 20–24 July 2020. Geneva: World Health Organization; 2020.

Collier SA, Deng L, Adam EA, Benedict KM, Beshearse EM, Blackstock AJ, et al. Estimate of burden and direct healthcare cost of infectious waterborne disease in the United States. Emerg Infect Dis. 2021;27(1):140–149. https://doi.org/10.3201/eid2701.190676

An X, Xiao L, Yang X, Tang X, Lai F, Liang XH. Economic burden of public health care and hospitalisation associated with COVID‑19 in China. Public Health. 2022;203:65–74. https://doi.org/10.1016/j.puhe.2021.12.001

Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 69 Tahun 2013 tentang Standar Tarif Pelayanan Kesehatan pada Fasilitas Kesehatan Tingkat Pertama dan Fasilitas Kesehatan Tingkat Lanjutan dalam Penyelenggaraan Program Jaminan Kesehatan. Indonesia; 2013.

Tandah MR, Diana K, Adisaputra AD, Monica S, Azzahrah F. Direct medical costs and accordance of INA‑CBG’s claims on COVID‑19 patients at Anutapura Hospital. J Farm Galenika. 2023;9(1):71–83. https://doi.org/10.22487/j24428744.2023.v9.i1.16073

Swandayana PGW, Sastrawan S. Analysis of the difference between INA‑CBG rates and hospital rates for outpatient and inpatient services at FKRTL provider BPJS Kesehatan Mataram City. Prisma Sains. 2021;9(2):246–252. https://doi.org/10.33394/j-ps.v9i2.4350

Giancotti M, Ciconte V, Mauro M. Social reporting in healthcare sector: the case of Italian public hospitals. Sustainability. 2022;14:15940. https://doi.org/10.3390/su142315940

Andrianto W, Kusumayaningtyas RV, Muthiarani R. Hospital social function reviewed from the health law (verdict analysis No. 381/Pid.B/2014/PN.TK and Baby Debora case). Soepra. 2021;7(1):40–56. https://doi.org/10.24167/shk.v7i1.2714

Kementerian Kesehatan Republik Indonesia. KMK No. HK.01.07/Menkes/6577/2020: Penetapan RSPI Sulianti Saroso sebagai Center of Excellence (CoE) Penyakit Infeksi dalam Sistem Ketahanan Kesehatan Nasional dan Integrasi Fungsional dengan Unit Utama Kemenkes. Indonesia: Kementerian Kesehatan RI; 2020.